439 related articles for article (PubMed ID: 25210168)
1. Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection.
Cohen K; Altfeld M; Alter G; Stamatatos L
J Virol; 2014 Nov; 88(22):13310-21. PubMed ID: 25210168
[TBL] [Abstract][Full Text] [Related]
2. Circulating CXCR5
Martin-Gayo E; Cronin J; Hickman T; Ouyang Z; Lindqvist M; Kolb KE; Schulze Zur Wiesch J; Cubas R; Porichis F; Shalek AK; van Lunzen J; Haddad EK; Walker BD; Kaufmann DE; Lichterfeld M; Yu XG
JCI Insight; 2017 Jan; 2(2):e89574. PubMed ID: 28138558
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses.
Ranasinghe S; Soghoian DZ; Lindqvist M; Ghebremichael M; Donaghey F; Carrington M; Seaman MS; Kaufmann DE; Walker BD; Porichis F
J Virol; 2015 Dec; 90(5):2208-20. PubMed ID: 26656715
[TBL] [Abstract][Full Text] [Related]
4. Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.
Locci M; Havenar-Daughton C; Landais E; Wu J; Kroenke MA; Arlehamn CL; Su LF; Cubas R; Davis MM; Sette A; Haddad EK; ; Poignard P; Crotty S
Immunity; 2013 Oct; 39(4):758-69. PubMed ID: 24035365
[TBL] [Abstract][Full Text] [Related]
5. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
McGuire AT; Glenn JA; Lippy A; Stamatatos L
J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
[TBL] [Abstract][Full Text] [Related]
6. Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1.
Sather DN; Carbonetti S; Malherbe DC; Pissani F; Stuart AB; Hessell AJ; Gray MD; Mikell I; Kalams SA; Haigwood NL; Stamatatos L
J Virol; 2014 Nov; 88(22):12968-81. PubMed ID: 25122781
[TBL] [Abstract][Full Text] [Related]
7. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers.
Buranapraditkun S; Pissani F; Teigler JE; Schultz BT; Alter G; Marovich M; Robb ML; Eller MA; Martin J; Deeks S; Michael NL; Streeck H
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468877
[TBL] [Abstract][Full Text] [Related]
8. Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses.
Nicholas KJ; Flaherty DK; Smith RM; Sather DN; Kalams SA
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):72-80. PubMed ID: 27509243
[TBL] [Abstract][Full Text] [Related]
9. Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors.
Swathirajan CR; Nandagopal P; Vignesh R; Srikrishnan AK; Goyal R; Qureshi H; Saravanan S; Solomon SS; Hanna LE; Sivasankaran MP; Singla N; Mukherjee J; Chatrath S; Kopycinski J; Murugavel KG
Pathog Dis; 2019 Jun; 77(4):. PubMed ID: 31505637
[TBL] [Abstract][Full Text] [Related]
10. Single and coexpression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza virus infection.
Elsner RA; Ernst DN; Baumgarth N
J Virol; 2012 Jul; 86(13):7146-57. PubMed ID: 22532671
[TBL] [Abstract][Full Text] [Related]
11. 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.
Kobie JJ; Alcena DC; Zheng B; Bryk P; Mattiacio JL; Brewer M; Labranche C; Young FM; Dewhurst S; Montefiori DC; Rosenberg AF; Feng C; Jin X; Keefer MC; Sanz I
PLoS One; 2012; 7(4):e35356. PubMed ID: 22530008
[TBL] [Abstract][Full Text] [Related]
12. Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.
Borrow P; Moody MA
Immunol Rev; 2017 Jan; 275(1):62-78. PubMed ID: 28133804
[TBL] [Abstract][Full Text] [Related]
13. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production.
Perreau M; Savoye AL; De Crignis E; Corpataux JM; Cubas R; Haddad EK; De Leval L; Graziosi C; Pantaleo G
J Exp Med; 2013 Jan; 210(1):143-56. PubMed ID: 23254284
[TBL] [Abstract][Full Text] [Related]
14. Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.
Roider J; Porterfield JZ; Ogongo P; Muenchhoff M; Adland E; Groll A; Morris L; Moore PL; Ndung'u T; Kløverpris H; Goulder PJR; Leslie A
Front Immunol; 2019; 10():1497. PubMed ID: 31333650
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes.
Ditse Z; Muenchhoff M; Adland E; Jooste P; Goulder P; Moore PL; Morris L
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950423
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint modulation enhances HIV-1 antibody induction.
Bradley T; Kuraoka M; Yeh CH; Tian M; Chen H; Cain DW; Chen X; Cheng C; Ellebedy AH; Parks R; Barr M; Sutherland LL; Scearce RM; Bowman CM; Bouton-Verville H; Santra S; Wiehe K; Lewis MG; Ogbe A; Borrow P; Montefiori D; Bonsignori M; Anthony Moody M; Verkoczy L; Saunders KO; Ahmed R; Mascola JR; Kelsoe G; Alt FW; Haynes BF
Nat Commun; 2020 Feb; 11(1):948. PubMed ID: 32075963
[TBL] [Abstract][Full Text] [Related]
17. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection.
Boswell KL; Paris R; Boritz E; Ambrozak D; Yamamoto T; Darko S; Wloka K; Wheatley A; Narpala S; McDermott A; Roederer M; Haubrich R; Connors M; Ake J; Douek DC; Kim J; Petrovas C; Koup RA
PLoS Pathog; 2014 Jan; 10(1):e1003853. PubMed ID: 24497824
[TBL] [Abstract][Full Text] [Related]
18. B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth.
Boliar S; Murphy MK; Tran TC; Carnathan DG; Armstrong WS; Silvestri G; Derdeyn CA
J Virol; 2012 Aug; 86(15):8031-40. PubMed ID: 22623771
[TBL] [Abstract][Full Text] [Related]
19. Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.
Mabvakure BM; Scheepers C; Garrett N; Abdool Karim S; Williamson C; Morris L; Moore PL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567996
[TBL] [Abstract][Full Text] [Related]
20. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.
Gray ES; Madiga MC; Hermanus T; Moore PL; Wibmer CK; Tumba NL; Werner L; Mlisana K; Sibeko S; Williamson C; Abdool Karim SS; Morris L;
J Virol; 2011 May; 85(10):4828-40. PubMed ID: 21389135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
